Article Text

other Versions

PDF
Phenotypic variability in Rett syndrome associated with FOXG1 mutations in females
  1. C Philippe (c.philippe{at}chu-nancy.fr)
  1. Laboratoire de Génétique Médicale, Nancy Université, EA 4002, France
    1. D Amsallem (damsallem{at}chu-besancon.fr)
    1. Service de Neuropédiatrie, Hôpital St Jacques, Besançon, France
      1. C Francannet (cfrancannet{at}chu-clermontferrand.fr)
      1. Service de Génétique Médicale, CHU Hôtel-Dieu, Clermont-Ferrand, France
        1. L Lambert (laebela{at}yahoo.fr)
        1. Service de Médecine Infantile I, Hôpital d'Enfants, CHU, NANCY, France
          1. A Saunier (a.quenard{at}chu-nancy.fr)
          1. Laboratoire de Génétique Médicale, Nancy Université, EA 4002, France
            1. F Verneau (f.verneau{at}chu-nancy.fr)
            1. Laboratoire de Génétique Médicale, Nancy Université, EA 4002, France
              1. P Jonveaux (p.jonveaux{at}chu-nancy.fr)
              1. Laboratoire de Génétique Médicale, Nancy Université, EA 4002, France

                Abstract

                Background: The FOXG1 gene has been recently implicated in the congenital form of Rett syndrome (RTT). It encodes the Forkhead box protein G1, a winged-helix transcriptional repressor with expression restricted to testis and brain where it is critical for forebrain development. So far, only two point mutations in FOXG1 have been reported in females affected by the congenital form of RTT.

                Aim: To assess the implication of FOXG1 in the molecular aetiology of classical RTT syndrome and related disorders.

                Methods: We screened the entire multi-exon coding sequence of FOXG1 for point mutations and large rearrangements in a cohort of 35 MECP2/CDKL5 mutation-negative female individuals including 31 classical and 4 congenital forms of RTT.

                Results: We identified two different de novo heterozygous FOXG1 truncating mutations. The individual with the p.Trp308X mutation presented with a severe RTT-like neurodevelopment disorder, whereas the p.Tyr400X allele was associated with a classical clinical RTT presentation.

                Conclusions: These new cases give additional support to the genetic heterogeneity in RTT, and help to delineate the clinical spectrum in the FOXG1-related phenotypes. FOXG1 screening should be considered in the molecular diagnosis of RTT.

                Statistics from Altmetric.com

                Request permissions

                If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.